Process and Manufacture
We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
Explore further
We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs
We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
Explore further
百奥泰生物制 药 股份申博体育 ( 上交所代 码 ： 申博体育) 是一家位于中国广州，基于科学而 创 新的申博体育生物制 药 企 业 ，以下 简 称 “ 百奥泰 ” 或 “...
Guangzhou, China– June 2 , 2024 – Bio-Thera Solutions Inc. (申博体育:SH), a commercial-stage biopharmaceutical companydeveloping a pipeline of innovative therapies and biosimilars, will present apost...
Bio-Theraand STADA h ave reached an exclusive commercialization and license agreement forBAT2506, a biosimilar candidate to Simponi ® (golimumab) Bio-Thera will maintain responsibility fordevelopment,...
